作者
Pakpoom Janewongwirot, Watsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Orawan Anunsittichai, Wachiraporn Saengseesom, Supranee Buranapraditkun, Jiratchaya Sophonphan, Noppadol Wacharachaisurapol, Nattapong Jitrungruengnij, Chitsanu Pancharoen, Thanyawee Puthanakit
发表日期
2019/8/23
期刊
Vaccine
卷号
37
期号
36
页码范围
5307-5313
出版商
Elsevier
简介
Background
World Health Organization changed the recommendation for pre-exposure rabies prophylaxis from 3-dose to 2-dose regimen in 2018. Given limited data of 2-dose regimens in pediatric population, this study aimed to compare the immunogenicity between 2-dose and 3-dose pre-exposure rabies immunization.
Methods
This study was conducted among healthy children aged 2–12 years. They were randomized to 2-dose vaccination (2D) on days 0 and 28 or 3-dose vaccination (3D) on days 0, 7, and 28. Purified Vero cell rabies vaccine (PVRV-Verorab™) was administered intramuscularly. Rabies virus neutralizing antibody (RVNA) titers were measured at 3 time points: 14-day after complete vaccination, 1-year pre-booster vaccination, and 7-day post-booster dose to mimic scenario of rabies exposure. RVNA titers ≥0.5 IU/ml were considered adequate antibody. T cell specific response to rabies …
引用总数
2020202120222023202412112